La Varenne Saint Hilaire, France

Italina Cerutti

This inventor holds 1 USPTO granted patent. Top assignee: Association Pour Le Développement De La Biothérapie Expérimentale Et Appliquée. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Italina Cerutti: Innovator in Biotherapy

Introduction

Italina Cerutti is a notable inventor based in La Varenne Saint Hilaire, France. She has made significant contributions to the field of biotherapy, particularly through her innovative research and patent in the area of lectinic properties.

Latest Patents

Cerutti holds a patent for "Compounds having lectinic properties and their biological applications." This invention relates to nucleotide sequences capable of coding for polypeptides with lectinic properties, specifically those of the sarcolectin type. The patent outlines their therapeutic uses, including the stimulation of immunity, potentially in combination with interferon or butyroids. Additionally, the invention discusses the use of specific inhibitors or antagonist peptides to counteract the production of SCL. Antibodies directed against these peptides can be utilized in diagnostics and therapeutics.

Career Highlights

Cerutti is affiliated with the Association Pour Le Développement De La Biothérapie Expérimentale Et Appliquée, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of polypeptides and their applications in medicine.

Collaborations

Cerutti collaborates with esteemed colleagues, including Aboubacar Kaba and Francoise Chany-Fournier, who contribute to her research endeavors.

Conclusion

Italina Cerutti's innovative work in biotherapy and her patent on lectinic compounds highlight her significant role in advancing therapeutic applications. Her contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…